يعرض 1 - 10 نتائج من 371 نتيجة بحث عن '"AKHAN, SILA"', وقت الاستعلام: 1.48s تنقيح النتائج
  1. 1
    دورية أكاديمية

    مصطلحات موضوعية: Antiretroviral, ART, HIV, Rapid start

    وصف الملف: application/pdf

    العلاقة: International Journal of General Medicine; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Yıldırım, F. S., Candevir, A., Akhan, S., Kaya, S., Çabalak, M., Ersöz, G., … Çelen, M. K. (2023). Rapid initiation of antiretroviral therapy. International Journal of General Medicine, 16, 1867–1877. https://doi.org/10.2147/IJGM.S393370Test; https://doi.org/10.2147/IJGM.S393370Test; https://hdl.handle.net/20.500.12428/5420Test; 16; 1867; 1877; Q3; WOS:000994365300001; 2-s2.0-85160296181; PMID: 37213471

  2. 2
    دورية أكاديمية
  3. 3
  4. 4
    دورية أكاديمية

    العلاقة: Lancet; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; https://hdl.handle.net/11454/76920Test; https://doi.org/10.1016/S0140-6736Test(21)01429-X; Aksu, Kurtuluş/0000-0001-6195-1158; Cinar, Gule/0000-0002-7635-8848; yavuz, serap şimşek/0000-0002-4675-169X; kilinc toker, aysin/0000-0002-6775-1234; Yıldırmak, Mustafa Taner/0000-0001-7006-7161; Korten, VolkanO/0000-0002-9991-814X; Ozkul, Aykut/0000-0001-5008-9443; 398; 10296; 213; 222

  5. 5
    دورية أكاديمية
  6. 6
  7. 7
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: Turkish Journal of Gastroenterology; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Demirtürk, N., Aygen, B., Çelik, İ., Mıstık, R., Akhan, S. ve Barut, S. (2021). Real-world data from Turkey: Is sofosbuvir/ledipasvir with or without ribavirin treatment for chronic Hepatitis C really effective?. Turkish Journal of Gastroenterology, 32(2), 155-163. https://doi.org/10.5152/tjg.2020.19569Test; https://www.turkjgastroenterol.org/en/real-world-data-from-turkey-is-sofosbuvir-ledipasvir-with-or-without-ribavirin-treatment-for-chronic-hepatitis-c-really-effective-136736Test; https://hdl.handle.net/11468/10264Test; 32; 155; 163; WOS:000648816400007; 2-s2.0-85106497950; https://search.trdizin.gov.tr/yayin/detay/511870Test; Q3; Q4

  8. 8
    دورية أكاديمية

    المساهمون: Altunok, Elif Sargin, Sayan, Murat, Akhan, Sila, Aygen, Bilgehan, Yildiz, Orhan, Koruk, Suda Tekin, Mistik, Resit, Zonguldak Bülent Ecevit Üniversitesi

    العلاقة: INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; 50; https://dx.doi.org/10.1016/j.ijid.2016.07.003Test; https://hdl.handle.net/20.500.12628/3180Test

  9. 9
    دورية أكاديمية

    المساهمون: İstinye Üniversitesi, Hastane, Fatih Ensaroğlu / 0000-0002-5474-8562, Ensaroğlu, Fatih, Fatih Ensaroğlu / EUA-5682-2022, Fatih Ensaroğlu / 37037277000

    وصف الملف: application/pdf

    العلاقة: International Journal of Infectious Diseases; Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı; Sayan, M., Yildirim, F. S., Akhan, S., Yildirim, A. A., Sirin, G., Cabalak, M., … Deveci, A. (2020). NS5A resistance - associated substitutions in chronic hepatitis C patients with direct acting antiviral treatment failure in Turkey. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 95, 84–89. https://doi.org/10.1016/j.ijid.2020.03.061Test; https://doi.org/10.1016/j.ijid.2020.03.061Test; https://hdl.handle.net/20.500.12713/398Test; 95; 84; 89

  10. 10
    دورية أكاديمية

    وصف الملف: application/pdf

    العلاقة: Turkish Journal of Gastroenterology; Makale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı; Aygen, B., Demirtürk, N., Yıldız, O., Çelen, M. K., Çelik, İ., Barut, Ş. ve diğerleri. (2020). Real-world efficacy, safety, and clinical outcomes of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin combination therapy in patients with hepatitis C virus genotype 1 or 4 infection: The Turkey experience experience. Turkish Journal of Gastroenterology, 31(4), 305-317.; https://www.turkjgastroenterol.org/en/real-world-efficacy-safety-and-clinical-outcomes-of-ombitasvir-paritaprevir-ritonavir-dasabuvir-ribavirin-combination-therapy-in-patients-with-hepatitis-c-virus-genotype-1-or-4-infection-the-turkey-experience-experience-136659Test; https://hdl.handle.net/11468/7219Test; 31; 305; 317; WOS:000535263200004; 2-s2.0-85084787334; https://search.trdizin.gov.tr/yayin/detay/419482Test; Q3; Q4